Agrify Corporation AGFY stock plummeted 30% on April 19, just days after a regulatory filing revealed that the company's financial statements "should no longer be relied upon."
Accountants at Marcum LLP are scrutinizing three different Agrify fiscal periods; those ending on March 31, 2022, June 30, 2022 and Sept. 30, 2022.
Agrify is planning to raise up to $1.84 million from the exercise of 10.65 million common stock warrants, and reduce the exercise price of all the existing warrants from $0.65 per share to $0.1725 per share.
Agrify's Audit Committee concluded that 301,575 warrants issued in a private placement on Jan. 28, 2022 and 688,111 warrants issued in a private placement on March 23, 2022 should have been classified as a liability measured at fair value, rather than as a component of equity.
The change in fair value of the warrants is a non-cash charge and is expected to be reflected in Agrify’s statement of operations.
Agrify stock opened Friday, April 21 at 20 cents. It was up 2.97% at the time of writing.
Related News
- Agrify Stock Plummets On Agreement To Raise Up To $1.84M From The Exercise Of Previously Issued Common Stock Warrants
- Agrify Announces Completion Of Total Turnkey Cultivation Facility Denver Greens Pending Final Inspection
- Las Vegas Facility Expected To Be Ready To Grow Cannabis In 132 Of Agrify's Units This April
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.